Corinne Jenkins

Stock Analyst at Goldman Sachs

(2.45)
# 3,206
Out of 5,182 analysts
59
Total ratings
45.65%
Success rate
2.18%
Average return

Stocks Rated by Corinne Jenkins

IDEAYA Biosciences
Apr 14, 2026
Maintains: Neutral
Price Target: $31$35
Current: $29.04
Upside: +20.52%
Roivant Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $24$33
Current: $27.77
Upside: +18.83%
Rhythm Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $141$157
Current: $84.18
Upside: +86.51%
Geron
Jul 10, 2025
Reinstates: Sell
Price Target: $1
Current: $1.51
Upside: -33.77%
TG Therapeutics
Nov 5, 2024
Maintains: Neutral
Price Target: $20$22
Current: $34.58
Upside: -36.38%
Fulcrum Therapeutics
May 14, 2024
Upgrades: Buy
Price Target: $6$15
Current: $7.44
Upside: +101.61%
Altimmune
Jan 24, 2024
Reinstates: Neutral
Price Target: $13
Current: $2.74
Upside: +374.45%
Harmony Biosciences Holdings
Jan 9, 2024
Maintains: Sell
Price Target: $25$28
Current: $31.16
Upside: -10.14%
BioXcel Therapeutics
Aug 15, 2023
Maintains: Neutral
Price Target: $192$64
Current: $1.06
Upside: +5,937.74%
Aclaris Therapeutics
Mar 7, 2023
Maintains: Buy
Price Target: $25$21
Current: $4.22
Upside: +397.63%
Maintains: Buy
Price Target: $9$14
Current: $52.94
Upside: -73.55%